We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Genomic Duplication Responsible for Rare Skin Disease

By LabMedica International staff writers
Posted on 15 May 2017
Print article
Image: A biopsy from the sole of the foot showing a recovered granular layer and a layer of parakeratosis sandwiched between the old orthokeratotic stratum corneum and a re-established orthokeratotic layer (Photo courtesy of SAMJ).
Image: A biopsy from the sole of the foot showing a recovered granular layer and a layer of parakeratosis sandwiched between the old orthokeratotic stratum corneum and a re-established orthokeratotic layer (Photo courtesy of SAMJ).
Through data analysis, ancestry mapping, genomic comparison, and international collaboration, researchers have identified the genetic mutation that causes the rare skin disease keratolytic winter erythema (KWE), or “Oudtshoorn skin,” in South African and Norwegian families.

Researchers at University of the Witwatersrand led the study in collaboration with peers in Europe, the USA, and Canada. KWE causes a redness of the palms and soles with consecutive cycles of peeling of large sections of thick skin, often exacerbated during winter months. Oudtshoorn is a town in the Western Cape province of South Africa where the disorder was present in large families.

Afrikaners, the Afrikaans-language speakers descended from predominantly Dutch, German, and French settlers in South Africa, have a high risk for several genetic disorders (e.g. familial hypercholesterolaemia, porphyria, and the lesser known KWE) because of founder mutations brought by small groups who settled in the Cape of Good Hope and whose descendants are now spread throughout South Africa.

In 1977 KWE was found to occur with a dominant mode of inheritance (so, on average, if a parent has the condition about half the children inherit it in every generation). This early research has enabled dermatologists to make a definitive diagnosis and helped researchers better understand similar skin disorders.

In 1997, student Michelle Starfield guided by Michèle Ramsay, professor at Witz, and a group in Germany mapped the KWE trait to a region on the short arm of chromosome 8. The researchers showed that it was likely that the South African families all had the same mutation but that the German family had a different mutation. Later research focused on characterizing this region of the genome and examining good candidate genes. The KWE mutation remained elusive.

Subsequently, Wits student Thandiswa Ngcungcu, supervised by Prof. Ramsay, investigated KWE with large-scale DNA sequencing during an internship in Novartis, Basel. The mutation was not detected by conventional data analysis so copy-number variants (duplications or deletions) were investigated. Ngcungcu and colleagues discovered a duplication mutation in a genomic region between genes that was present in all South African KWE-affected individuals studied.

During this time Dr Torunn Fiskerstrand, University of Bergen, Norway, independently discovered a genomic duplication as the cause KWE in Norwegians. Ramsay and Fiskerstrand collaborated. The different DNA duplications in the South African and Norwegian families overlapped at a critical enhancer region, providing strong evidence that this was the KWE-causing mutation.

The scientists researched how this duplicated enhancer caused KWE and discovered that the mutation causes a nearby gene, CTSB, to produce more protein than normal and that this abnormal expression was the likely cause of the skin peeling disorder.

The study, by Ngcungcu T et al, was published in the May 2017 issue of the American Journal of Human Genetics.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.